Clinical Trials Logo

Tast Perference clinical trials

View clinical trials related to Tast Perference.

Filter by:
  • None
  • Page 1

NCT ID: NCT04232033 Active, not recruiting - Tast Perference Clinical Trials

The Physiological Effects of FGF21 on Alcohol Preference and Glucose Metabolism

AlcoPref
Start date: May 1, 2021
Phase: N/A
Study type: Interventional

The primary objective is to evaluate taste preferences for alcohol during an intravenous infusion of the naturally occurring hormone fibroblast growth factor-21 (FGF21) and placebo (i.e. saline), respectively, in 20 healthy subjects. Secondary endpoints are to evaluate the effects of exogenous FGF21 (compared to placebo) on resting energy expenditure, preference for salt, sour and bitter taste qualities, sensations of hunger, thirst, appetite, satiety, headache and nausea, and makers of glucose metabolism (e.g. plasma/serum concentrations of glucose, C-peptide, insulin and glucagon).